Project Grant G2649918

This federal Project Grant award from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) totaling $945,397 provides funding to the Magee-Womens Research Institute and Foundation, with a sub-award to the University of Pittsburgh, to adapt and evaluate a collaborative care model (CCM) for treating pregnant persons with opioid use disorder (OUD) in low-resource obstetric settings. The key objectives are to: 1) adapt the CCM for rural and low-resource...

This $3,503,736 federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will support the development and testing of a multilevel substance use disorder (SUD) and overdose prevention strategy for rural youth involved in the county legal system. The 2-year R61 phase will co-design the multilevel SUD/overdose prevention strategy and an implementation plan for rural juvenile court systems. The subsequent 3-year...

The National Institute on Drug Abuse (NIDA) awarded The Washington University a 3-year, $2,337,729 Project Grant under the Drug Abuse and Addiction Research Programs (CFDA 93.279) to study the impact of prenatal opioid exposure on placental and fetal brain development. The project, titled "The Opioid in Pregnancy: Imaging of Oxygenation, Inflammation, and Development in Brain & Placenta" (OPIOID BPP), aims to define the longitudinal effects of prenatal opioid exposure on...

This $3,900,000 Congressional Directives Project Grant award from the Substance Abuse and Mental Health Services Administration (CFDA 93.493) aims to expand the capacity and support best practices in caring for infants in New Mexico with neonatal opioid withdrawal syndrome (NOWS). The University of New Mexico Health Sciences Center (UNM HSC) will use the funding to: Provide training and quality improvement coaching to 20-30 healthcare providers and nursing staff at 2-3 hospitals to optimize...

This $3,000,000.00 Rural Communities Opioid Response Program-Impact federal Project Grant was awarded by the Health Resources and Services Administration (HRSA) under the Rural Health Research Centers program (CFDA 93.155). The grant was awarded on September 1, 2024 to the Ohiohealth Research Institute, a non-profit hospital-based research organization in Columbus, Ohio. The award supports policy-relevant research and technical assistance to understand and address healthcare challenges faced...

The United Way of Rutherford County, Inc. has been awarded a $2,250,000 Project Grant from the Federal Office of Rural Health Policy under the Rural Health Research Centers (CFDA 93.155) program. The grant, titled "Rural Communities Opioid Response Program-IMPACT", aims to demonstrate the effectiveness of telehealth networks in improving rural emergency and neonatal healthcare services. The funding will be used to develop and implement telehealth-enabled interventions to address opioid...

This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), supports research to develop a translational rat model of the neonatal intensive care unit (NICU) experience and its impacts on substance use disorder risk. The $368,315 award to the Georgia State University Research Foundation will: 1) design and test a model combining early pain, resource scarcity, and separation from caregivers to mimic key aspects of...

This Project Grant award, funded by the Agency for Healthcare Research and Quality (AHRQ) under the Research on Healthcare Costs, Quality and Outcomes (CFDA 93.226) program, supports a comprehensive $398,972 study on improving healthcare quality and equity for newborns with prenatal substance exposure. The study, conducted by the University of California, Davis in collaboration with the Better Outcomes through Research for Newborns (BORN) network and the EMPOWER stakeholder group, aims to:...

The American Academy of Addiction Psychiatry (AAAP) received a $55,500,000 Project Grant award from the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program. The funding will support the Opioid Response Network (ORN), a collaborative network of over 50 national and regional healthcare organizations that provides training and technical assistance to address...

The Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) federal grant award, provided by the Substance Abuse and Mental Health Services Administration (SAMHSA), is funding the Nevada State Opioid Response (SOR) Program. The $83,174,470 award, with a project period of 9/30/2024 to 9/29/2027, aims to combat the opioid and stimulant crisis in Nevada by expanding treatment access, enhancing prevention strategies, strengthening harm reduction...